Spruce Biosciences, Inc. (SPRB) Stock Overview
Explore Spruce Biosciences, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Spruce Biosciences, Inc. (SPRB)
Key Financials
Key Financials
Market Cap
147.8M
P/E Ratio
-1.33
EPS (TTM)
$-39.78
ROE
-1.24%
SPRB Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Spruce Biosciences, Inc. (NASDAQ: SPRB) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Spruce Biosciences, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of SPRB on the NASDAQ shows an RSI of 47.90, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $87.56 for the NASDAQ listing.
Key metrics behind Spruce Biosciences, Inc.'s NASDAQ-traded stock include a P/E ratio of -1.33 and a market capitalization of 147.8M. Combined with our AI analysis, these give both institutional and retail investors a clear view of SPRB on the NASDAQ.